262 related articles for article (PubMed ID: 32016364)
1. Antifungal activity of promethazine and chlorpromazine against planktonic cells and biofilms of Cryptococcus neoformans/Cryptococcus gattii complex species.
Brilhante RSN; Gotay WJP; Pereira VS; de Oliveira JS; Pereira-Neto WA; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Rocha MFG
Med Mycol; 2020 Oct; 58(7):906-912. PubMed ID: 32016364
[TBL] [Abstract][Full Text] [Related]
2. Darunavir inhibits
Brilhante RSN; Silva JAT; Araújo GDS; Pereira VS; Gotay WJP; Oliveira JS; Guedes GMM; Pereira-Neto WA; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Rocha MFG
J Med Microbiol; 2020 Jun; 69(6):830-837. PubMed ID: 32459616
[No Abstract] [Full Text] [Related]
3. Antifolates inhibit Cryptococcus biofilms and enhance susceptibility of planktonic cells to amphotericin B.
de Aguiar Cordeiro R; Mourão CI; Rocha MF; de Farias Marques FJ; Teixeira CE; de Oliveira Miranda DF; Neto LV; Brilhante RS; de Jesus Pinheiro Gomes Bandeira T; Sidrim JJ
Eur J Clin Microbiol Infect Dis; 2013 Apr; 32(4):557-64. PubMed ID: 23192488
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of heat-shock protein 90 enhances the susceptibility to antifungals and reduces the virulence of Cryptococcus neoformans/Cryptococcus gattii species complex.
Cordeiro RA; Evangelista AJJ; Serpa R; Marques FJF; Melo CVS; Oliveira JS; Franco JDS; Alencar LP; Bandeira TJPG; Brilhante RSN; Sidrim JJC; Rocha MFG
Microbiology (Reading); 2016 Feb; 162(2):309-317. PubMed ID: 26645478
[TBL] [Abstract][Full Text] [Related]
5. Miltefosine Has a Postantifungal Effect and Induces Apoptosis in Cryptococcus Yeasts.
Spadari CC; Vila T; Rozental S; Ishida K
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844051
[No Abstract] [Full Text] [Related]
6. Antifungal Activity, Antibiofilm and Association Studies with O-Alkylamidoximes against Cryptococcus spp.
de Castro Teixeira AP; Fernandes Queiroga Moraes G; de Oliveira RJ; Silva Santos C; Alves Caiana RR; Rufino de Freitas JC; Vasconcelos U; de Oliveira Pereira F; Oliveira Lima I
Chem Biodivers; 2023 Mar; 20(3):e202200539. PubMed ID: 36730650
[TBL] [Abstract][Full Text] [Related]
7. Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods.
Nishikawa MM; Almeida-Paes R; Brito-Santos F; Nascimento CR; Fialho MM; Trilles L; Morales BP; da Silva SA; Santos W; Santos LO; Fortes ST; Cardarelli-Leite P; Lázera MDS
Med Mycol; 2019 Oct; 57(7):864-873. PubMed ID: 30657975
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory activity of isoniazid and ethionamide against Cryptococcus biofilms.
Cordeiro Rde A; Serpa R; Marques FJ; de Melo CV; Evangelista AJ; Mota VF; Brilhante RS; Bandeira Tde J; Rocha MF; Sidrim JJ
Can J Microbiol; 2015 Nov; 61(11):827-36. PubMed ID: 26362025
[TBL] [Abstract][Full Text] [Related]
9. Control of
Almeida-Apolonio AA; Cupozak-Pinheiro WJ; Berres VM; Dantas FGS; Svidzinski TIE; Oliveira KMP; Chang MR
ScientificWorldJournal; 2018; 2018():5764187. PubMed ID: 29977170
[No Abstract] [Full Text] [Related]
10. Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro.
Martinez LR; Casadevall A
Antimicrob Agents Chemother; 2006 Mar; 50(3):1021-33. PubMed ID: 16495265
[TBL] [Abstract][Full Text] [Related]
11. Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India.
Gutch RS; Nawange SR; Singh SM; Yadu R; Tiwari A; Gumasta R; Kavishwar A
Braz J Microbiol; 2015; 46(4):1125-33. PubMed ID: 26691471
[TBL] [Abstract][Full Text] [Related]
12. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
Hagen F; Hare Jensen R; Meis JF; Arendrup MC
Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
[TBL] [Abstract][Full Text] [Related]
13. Heterocycle Thiazole Compounds Exhibit Antifungal Activity through Increase in the Production of Reactive Oxygen Species in the Cryptococcus neoformans-Cryptococcus gattii Species Complex.
Sá NP; Lima CM; Lino CI; Barbeira PJS; Baltazar LM; Santos DA; Oliveira RB; Mylonakis E; Fuchs BB; Johann S
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533240
[TBL] [Abstract][Full Text] [Related]
14. Antifungal and antibiofilm effect of duloxetine hydrochloride against Cryptococcus neoformans and Cryptococcus gattii.
Rehem AR; da Gama Viveiro LR; De Souza Santos EL; do Carmo PHF; da Silva NS; Junqueira JC; Scorzoni L
Folia Microbiol (Praha); 2024 Apr; ():. PubMed ID: 38652436
[TBL] [Abstract][Full Text] [Related]
15. Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for the Cryptococcus neoformans-Cryptococcus gattii species complex using the CLSI M27-A3 broth microdilution method.
Espinel-Ingroff A; Chowdhary A; Gonzalez GM; Guinea J; Hagen F; Meis JF; Thompson GR; Turnidge J
Antimicrob Agents Chemother; 2015 Jan; 59(1):666-8. PubMed ID: 25313209
[TBL] [Abstract][Full Text] [Related]
16. Pyrifenox, an ergosterol inhibitor, differentially affects Cryptococcus neoformans and Cryptococcus gattii.
Silva VKA; May RC; Rodrigues ML
Med Mycol; 2020 Oct; 58(7):928-937. PubMed ID: 31915833
[TBL] [Abstract][Full Text] [Related]
17. Cryptococcus neoformans and C. gattii isolates from both HIV-infected and uninfected patients: antifungal susceptibility and outcome of cryptococcal disease.
Nascimento E; Vitali LH; Kress MRVZ; Martinez R
Rev Inst Med Trop Sao Paulo; 2017; 59():e49. PubMed ID: 28793019
[TBL] [Abstract][Full Text] [Related]
18. In vitro Antifungal Activity of a Novel Antimicrobial Peptide AMP-17 Against Planktonic Cells and Biofilms of
Yang L; Tian Z; Zhou L; Zhu L; Sun C; Huang M; Peng J; Guo G
Infect Drug Resist; 2022; 15():233-248. PubMed ID: 35115792
[TBL] [Abstract][Full Text] [Related]
19. Cryptococcus neoformans/Cryptococcus gattii species complex melanized by epinephrine: Increased yeast survival after amphotericin B exposure.
Brilhante RSN; Rocha MGD; Oliveira JS; Pereira-Neto WA; Guedes GMM; Cordeiro RA; Sidrim JJC; Rocha MFG; Castelo-Branco DSCM
Microb Pathog; 2020 Jun; 143():104123. PubMed ID: 32169493
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility profile of clinical and environmental isolates of Cryptococcus neoformans and Cryptococcus gattii in Uberaba, Minas Gerais, Brazil.
Andrade-Silva L; Ferreira-Paim K; Mora DJ; Da Silva PR; Andrade AA; Araujo NE; Pedrosa AL; Silva-Vergara ML
Med Mycol; 2013 Aug; 51(6):635-40. PubMed ID: 23343452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
